NO20002590L - Formuleringer omfattende oppløst paroxetin - Google Patents

Formuleringer omfattende oppløst paroxetin

Info

Publication number: NO20002590L
Authority: NO; Norway
Prior art keywords: paroxetine; solid; formulations; solutions; dissolved
Prior art date: 1997-11-21

Application number

NO20002590A

Other languages

English (en)

Norwegian (no)

Other versions

NO20002590D0 (no

Inventor

Ahmad Ghazawi

Graham Stanley Leonard

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-11-21

Filing date

2000-05-19

Publication date

2000-07-19

2000-05-19 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2000-05-19 Publication of NO20002590D0 publication Critical patent/NO20002590D0/no

2000-07-19 Publication of NO20002590L publication Critical patent/NO20002590L/no

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 5
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 5
229960002296 paroxetine Drugs 0.000 title abstract 5
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1
239000007787 solid Substances 0.000 abstract 2
239000000243 solution Substances 0.000 abstract 2
239000002775 capsule Substances 0.000 abstract 1
239000012051 hydrophobic carrier Substances 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000012669 liquid formulation Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000003921 oil Substances 0.000 abstract 1
239000008188 pellet Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
239000000546 pharmaceutical excipient Substances 0.000 abstract 1
239000007909 solid dosage form Substances 0.000 abstract 1
239000006104 solid solution Substances 0.000 abstract 1
239000002904 solvent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

NO20002590A 1997-11-21 2000-05-19 Formuleringer omfattende oppløst paroxetin NO20002590L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9724544.3A GB9724544D0 (en)	1997-11-21	1997-11-21	Novel Formulation
PCT/GB1998/003471 WO1999026625A1 (fr)	1997-11-21	1998-11-18	Formulations contenant de la paroxetine dissoute

Publications (2)

Publication Number	Publication Date
NO20002590D0 NO20002590D0 (no)	2000-05-19
NO20002590L true NO20002590L (no)	2000-07-19

Family

ID=10822374

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20002590A NO20002590L (no)	1997-11-21	2000-05-19	Formuleringer omfattende oppløst paroxetin

Country Status (24)

Country	Link
EP (1)	EP1033986A1 (fr)
JP (1)	JP2001523718A (fr)
KR (1)	KR20010032320A (fr)
CN (1)	CN1279608A (fr)
AP (1)	AP2000001821A0 (fr)
AR (1)	AR015485A1 (fr)
AU (1)	AU1168099A (fr)
BG (1)	BG104527A (fr)
BR (1)	BR9814220A (fr)
CO (1)	CO4970832A1 (fr)
DZ (1)	DZ2658A1 (fr)
EA (1)	EA200000552A1 (fr)
GB (1)	GB9724544D0 (fr)
HU (1)	HUP0100580A3 (fr)
IL (1)	IL136106A0 (fr)
MA (1)	MA24704A1 (fr)
NO (1)	NO20002590L (fr)
OA (1)	OA11385A (fr)
PE (1)	PE20000381A1 (fr)
PL (1)	PL340555A1 (fr)
SK (1)	SK7342000A3 (fr)
TR (1)	TR200001423T2 (fr)
WO (1)	WO1999026625A1 (fr)
ZA (1)	ZA9810637B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9810180D0 (en) *	1998-05-13	1998-07-08	Smithkline Beecham Plc	Novel formulation
WO2000054775A1 (fr) *	1999-03-12	2000-09-21	Basf Ag	Forme galenique pharmaceutique stable pour anhydrate de paroxetine
DE60004768T2 (de)	1999-07-01	2004-07-08	Italfarmaco S.P.A.	Komplexe von paroxetin mit cyclodextrin oder cyclodextrin derivaten
DE19930454A1 (de) *	1999-07-02	2001-01-04	Knoll Ag	Feste Paroxetin enthaltende Zubereitungen
US6720003B2 (en)	2001-02-16	2004-04-13	Andrx Corporation	Serotonin reuptake inhibitor formulations
US7011846B2 (en) *	2001-12-21	2006-03-14	Shire Laboratories, Inc.	Oral capsule formulation with increased physical stability
SE0200475D0 (sv) *	2002-02-15	2002-02-15	Ltp Lipid Technologies Provide	Oral farmaceutisk beredning
WO2006119779A2 (fr) *	2005-05-10	2006-11-16	Lifecycle Pharma A/S	Composition pharmaceutique comprenant un antagoniste de l'aldosterone
JP2013512948A (ja) *	2009-12-08	2013-04-18	イル・ファ・カンパニー・リミテッド	２０−Ｏ−β−Ｄ−グルコピラノシル−２０（Ｓ）−プロトパナキサジオールを含む固体分散体
GB201020032D0 (en) *	2010-11-25	2011-01-12	Sigmoid Pharma Ltd	Composition
CN103961333B (zh) *	2014-05-07	2020-02-21	浙江华海药业股份有限公司	甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996031197A1 (fr) *	1995-04-03	1996-10-10	Abbott Laboratories	Melanges homogenes de medicaments fondant a basse temperature et d'additifs, destines a une liberation lente
HUP0000960A3 (en) *	1997-01-15	2001-04-28	Smithkline Beecham Plc	Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same

1997
- 1997-11-21 GB GBGB9724544.3A patent/GB9724544D0/en not_active Ceased
1998
- 1998-11-18 AU AU11680/99A patent/AU1168099A/en not_active Abandoned
- 1998-11-18 PL PL98340555A patent/PL340555A1/xx unknown
- 1998-11-18 EP EP98954631A patent/EP1033986A1/fr not_active Withdrawn
- 1998-11-18 PE PE1998001126A patent/PE20000381A1/es not_active Application Discontinuation
- 1998-11-18 AP APAP/P/2000/001821A patent/AP2000001821A0/en unknown
- 1998-11-18 DZ DZ980268A patent/DZ2658A1/fr active
- 1998-11-18 WO PCT/GB1998/003471 patent/WO1999026625A1/fr not_active Ceased
- 1998-11-18 CN CN98811404A patent/CN1279608A/zh active Pending
- 1998-11-18 JP JP2000521827A patent/JP2001523718A/ja active Pending
- 1998-11-18 EA EA200000552A patent/EA200000552A1/ru unknown
- 1998-11-18 HU HU0100580A patent/HUP0100580A3/hu unknown
- 1998-11-18 IL IL13610698A patent/IL136106A0/xx unknown
- 1998-11-18 TR TR2000/01423T patent/TR200001423T2/xx unknown
- 1998-11-18 KR KR1020007005532A patent/KR20010032320A/ko not_active Withdrawn
- 1998-11-18 BR BR9814220-8A patent/BR9814220A/pt not_active Application Discontinuation
- 1998-11-18 SK SK734-2000A patent/SK7342000A3/sk unknown
- 1998-11-19 MA MA25357A patent/MA24704A1/fr unknown
- 1998-11-19 AR ARP980105880A patent/AR015485A1/es unknown
- 1998-11-20 CO CO98068459A patent/CO4970832A1/es unknown
- 1998-11-20 ZA ZA9810637A patent/ZA9810637B/xx unknown
2000
- 2000-05-19 OA OA1200000153A patent/OA11385A/en unknown
- 2000-05-19 NO NO20002590A patent/NO20002590L/no not_active Application Discontinuation
- 2000-06-13 BG BG104527A patent/BG104527A/xx unknown

Also Published As

Publication number	Publication date
EA200000552A1 (ru)	2000-10-30
AP2000001821A0 (en)	2000-06-30
KR20010032320A (ko)	2001-04-16
PL340555A1 (en)	2001-02-12
AU1168099A (en)	1999-06-15
NO20002590D0 (no)	2000-05-19
CN1279608A (zh)	2001-01-10
OA11385A (en)	2004-01-27
TR200001423T2 (tr)	2000-10-23
IL136106A0 (en)	2001-05-20
WO1999026625A1 (fr)	1999-06-03
CO4970832A1 (es)	2000-11-07
BG104527A (en)	2001-04-30
BR9814220A (pt)	2001-12-26
ZA9810637B (en)	2000-05-22
HUP0100580A2 (hu)	2002-04-29
DZ2658A1 (fr)	2003-03-22
MA24704A1 (fr)	1999-07-01
PE20000381A1 (es)	2000-05-07
SK7342000A3 (en)	2000-12-11
JP2001523718A (ja)	2001-11-27
EP1033986A1 (fr)	2000-09-13
AR015485A1 (es)	2001-05-02
HUP0100580A3 (en)	2002-05-28
GB9724544D0 (en)	1998-01-21

Legal Events

Date	Code	Title	Description
2003-07-28	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
ES2191862T3 (es)	2003-09-16	Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18.
NO20002590L (no)	2000-07-19	Formuleringer omfattende oppløst paroxetin
GB2314508A (en)	1998-01-07	Diamide-dicarboxylic acid microspheres
DE69927963D1 (de)	2005-12-01	Gelierbare pharmazeutische zusammensetzungen
NO20002133D0 (no)	2000-04-26	Oppløsninger og dispersjoner i fast tilstand av svakt vannoppløselige legemidler
ES2196621T3 (es)	2003-12-16	Sistemas de administracion de farmacos que utilizan estructuras de cristal liquido.
DK0501985T3 (da)	1994-05-09	Uovertrukket farmaceutisk reaktionstablet
ATE215370T1 (de)	2002-04-15	Selbstemulgierende formulierung enthaltend lipophile verbindungen
DE69940674D1 (de)	2009-05-14	Orale verabreichung von adenosin analogen
ES8502333A1 (es)	1985-01-01	Un procedimiento para la preparacion de una tableta farmaceutica
DE58902457D1 (de)	1992-11-19	Retardierte arzneiform und verfahren zu ihrer herstellung.
DK1173153T3 (da)	2006-02-20	Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
ES2029776T1 (es)	1992-10-01	Procedimiento para la preparacion de composiciones farmaceuticas que contienen bromocriptina con una alta estabilidad.
SV2002000301A (es)	2002-06-07	Composicion farmaceutica ref. z-1032
RU2000131588A (ru)	2002-10-20	Фармацевтическая композиция
NO950134L (no)	1995-09-04	Formuleringer for oralt administrerte farmasöytiske midler
ES8402504A1 (es)	1984-02-01	Procedimiento para preparar capsulas de gelatina blanda de alcaloides del cornezuelo de centeno.
KR910011241A (ko)	1991-08-07	정제로 직접 압착 가능한 약제학적 분말 조성물을 제조하기 위한 분무 건조법
NO931697L (no)	1993-07-07	Lhrh-antagonister
ATE300293T1 (de)	2005-08-15	Pharmazeutische zusammensetzungen, die schwerlösliche arzneistoffe enthalten
Wiseman et al.	1964	The distribution, excretion and metabolism of benzquinamide
DE69416034D1 (de)	1999-03-04	Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen
JPS55129220A (en)	1980-10-06	Composition for solid preparation containing hardly soluble medicinal component having rapid action and high bioavailability
ES2064619T3 (es)	1995-02-01	Derivados tetrahidropiranilicos, procedimiento para su preparacion y composiciones farmaceuticas o veterinarias que los contienen.
JPS5251362A (en)	1977-04-25	Preparation of optically active pyrrolidine derivatives